Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: Product News

Product News

CLI 230823 doc imatge KapLam

KAPPA and LAMBDA assays, in serum and urine, for nephelometers and clinical chemistry analyzers

, 15 September 2023/in Product News /by panglobal

TRIMERO Diagnostics offers CE marked IVD assays for KAPPA and LAMBDA light chains (bound and free), for both urine and serum samples.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/09/CLI_230823_doc_imatge_KapLam.jpg 883 722 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-09-15 07:45:172023-09-15 07:45:52KAPPA and LAMBDA assays, in serum and urine, for nephelometers and clinical chemistry analyzers
PromoCells new GMP grade MSC medium

PromoCell introduces PromoExQ MSC Growth Medium XF for expansion of mesenchymal stem cells

, 13 September 2023/in Product News /by panglobal

PromoCell, a manufacturer of cell culture products, has introduced PromoExQ MSC Growth Medium XF, a serum- and xeno-free cell culture medium designed for GMP compliant maintenance and long-term expansion of mesenchymal stem cells (MSCs) for cell therapy manufacturing applications. 

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/09/PromoCells-new-GMP-grade-MSC-medium.jpg 1281 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-09-13 11:48:002023-09-13 11:48:00PromoCell introduces PromoExQ MSC Growth Medium XF for expansion of mesenchymal stem cells
Lonza

Lonza launches TheraPRO CHO Media System to improve productivity, quality in therapeutic protein manufacture

, 13 September 2023/in Product News /by panglobal

Lonza has launched the TheraPRO CHO Media System, a new cell culture platform that simplifies processes and optimizes productivity and protein quality when used with GS-CHO cell lines. The launch supports pharmaceutical and biotechnology companies manufacturing therapeutic proteins to further improve product quality while streamlining time-to-market.The EURORealTime SARS-CoV-2 from EUROIMMUN is now validated for use […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/09/Lonza.jpg 768 1024 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-09-13 11:43:082023-09-13 11:43:08Lonza launches TheraPRO CHO Media System to improve productivity, quality in therapeutic protein manufacture
shutterstock 663568582

Global Access Diagnostics reintroduces IT-Leish test for visceral leishmaniasis

, 13 September 2023/in Product News /by panglobal

Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, has introduced IT-Leish, a rapid diagnostic test (RDT) for visceral leishmaniasis (VL). The company acquired the manufacturing rights for IT-Leish from Bio-Rad in September 2022 to prevent its withdrawal from the market and has since ensured the regulatory requirements have been met for reintroduction […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/09/shutterstock_663568582.jpg 1280 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-09-13 11:39:472023-09-13 11:39:47Global Access Diagnostics reintroduces IT-Leish test for visceral leishmaniasis
tecan

Tecan’s Phase Separator advances automation for liquid biopsy and biobanking

, 13 September 2023/in Product News /by panglobal

Tecan has unveiled its Phase Separator, an innovative liquid separation technology that promises to save time and improve accuracy in laboratory workflows. With specific applications in liquid biopsy and biobanking, its benefits will be felt in genomics, proteomics and across multiple disease areas, from oncology and neurodegenerative disease to metabolic disorders.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/09/tecan.jpg 1071 1606 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-09-13 11:34:322023-09-13 11:35:21Tecan’s Phase Separator advances automation for liquid biopsy and biobanking
AutoKit 02

Gyros Protein Technologies introduces PurePep EasyClean Auto Kit for automated parallel peptide purification

, 13 September 2023/in Product News /by panglobal

Gyros Protein Technologies, a leading provider of peptide synthesizers and reagents, and a pioneer in automated nanolitre-scale immunoassays, has launched PurePep EasyClean (PEC) Auto Kit for the automated parallel purification of peptides, accelerating downstream processes for research, development, and production of simple to complex peptide drugs and therapies.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/09/AutoKit-02.jpg 1280 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-09-13 11:30:462023-09-13 11:31:03Gyros Protein Technologies introduces PurePep EasyClean Auto Kit for automated parallel peptide purification
Scherm­afbeelding 2023 09 13 om 12.37.22

Genomic Vision launches HexaCard, a new service to characterize cell lines for biomanufacturing and gene therapy

, 13 September 2023/in Product News /by panglobal

Genomic Vision, a biotechnology company that develops products and services for the characterization of DNA sequences, has launched a new service, HexaCard.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/09/Scherm­afbeelding-2023-09-13-om-12.37.22.jpg 936 1576 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-09-13 10:38:102023-09-13 10:38:10Genomic Vision launches HexaCard, a new service to characterize cell lines for biomanufacturing and gene therapy
Biostat STR

Sartorius and Repligen Corporation introduce integrated system with Biostat STR and XCell ATF for upstream process intensification

, 13 September 2023/in Product News /by panglobal

The life science group Sartorius and Repligen Corporation have launched of an integrated bioreactor system that incorporates Repligen XCell ATF upstream intensification technology into Sartorius’ Biostat STR bioreactor, simplifying intensified seed train and N perfusion implementation for biopharmaceuti­cal manufacturers. The Biostat STR now contains a fully compatible embedded XCell ATF hardware and software module offering […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/09/Biostat-STR.png 1703 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-09-13 10:33:592023-09-13 10:33:59Sartorius and Repligen Corporation introduce integrated system with Biostat STR and XCell ATF for upstream process intensification
Waters XBridge

Waters launches XBridge Premier GTx BEH SEC Columns for gene therapy applications

, 13 September 2023/in Product News /by panglobal

Waters Corporation has introduced the first in a new line of size exclusion chromatography (SEC) columns aimed at improving the analysis while lowering the cost of gene therapies, specifically adeno-associated viral (AAV) vectors. The new Waters XBridge Premier GTx BEH SEC columns doubles the speed of measuring the potency and safety of AAVs. Combining the […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/09/Waters-XBridge.jpg 472 868 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-09-13 10:30:042023-09-13 10:30:04Waters launches XBridge Premier GTx BEH SEC Columns for gene therapy applications
siemens healthineers atellica ci analyzer

Siemens Healthineers Atellica CI Analyzer for smaller labs receives FDA approval

, 13 September 2023/in Product News /by panglobal

Siemens Healthineers’ Atellica CI Analyzer for immunoassay and clinical chemistry testing, has received FDA clearance and is now available in many of the world’s major markets. It is the latest addition to the Siemens Healthineers Atellica in vitro diagnostics portfolio.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/09/siemens-healthineers-atellica-ci-analyzer.jpg 1080 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-09-13 10:10:142023-09-13 10:10:14Siemens Healthineers Atellica CI Analyzer for smaller labs receives FDA approval
Page 30 of 149«‹2829303132›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
13 November 2025

New Chromsystems Product for Antiepileptic Drugs Testing

11 November 2025

Trusted analytical solutions for reliable results

10 November 2025

Chromsystems | Therapeutic Drug Monitoring by LC-MS/MS

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription